Predicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA): results from BSRBR-AS

OBJECTIVES: While many axSpA patients, eligible to receive anti-TNFα therapy, derive benefit when prescribed them, some patients do not. The current study aims to identify modifiable targets to improve outcome as well as non-modifiable targets that identify groups less likely to derive benefit. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Macfarlane, Gary J, Pathan, Ejaz, Jones, Gareth T, Dean, Linda E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449799/
https://www.ncbi.nlm.nih.gov/pubmed/31990352
http://dx.doi.org/10.1093/rheumatology/kez657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449799/
https://www.ncbi.nlm.nih.gov/pubmed/31990352
http://dx.doi.org/10.1093/rheumatology/kez657

Ejemplares similares